1.
Bioorg Med Chem Lett
; 16(10): 2724-8, 2006 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16540318
RESUMO
An imidazolylpyrimidine was identified in a CXCR2 chemokine receptor antagonist screen and was optimized for potency, in vitro metabolic stability, and oral bioavailability. It was found that subtle structural modification within the series affected the oral bioavailability. Potent and orally available CXCR2 antagonists are herein reported.